机译:Exclusion of the phosphoinositide-specific phospholipase Cβ3 (PLCB3) gene as a candidate for multiple endocrine neoplasia type 1
Department of Molecular Medicine, L6 building, Karolinska Hospital, S-171 76 Stockholm, Sweden Tel.: +46-8-7293923;
Fax: +46-8-327734;
Queensland Cancer Fund Research Unit, Joint Experimental Oncology Program, Queensland Institute of Medical Research, Herston, QLD, 4029, Australia;
The Oncogenetics Unit, Institute of Genetics, Chaim Sheba Medical Center, Tel-Hashomer, 52621, Israel;